Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    17893227 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bendamustine;   Drug: Lenalidomide;   Drug: Dexamethasone
2 Recruiting Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: Lenalidomide
3 Completed Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: CC-5013

Indicates status has not been verified in more than two years